EVALUATION OF ADVERSE EFFECTS OF HYPOTHYROIDISM DURING ANTENATAL PERIOD WITH MATERNAL AND FETAL OUTCOMES IN SUBJECTS WITH SUBCLINICAL AND OVERT HYPOTHYROIDISM
DOI:
https://doi.org/10.22159/ajpcr.2024.v17i2.48651Keywords:
Fetal complications, Maternal complications, Maternal hypothyroidism, Thyroid hormonesAbstract
Objectives: Maternal thyroid hormone excess or deficiency can influence the outcome of the mother and fetus at all stages of pregnancy as well as interfere with ovulation and infertility. In females who suffer from thyroid diseases before pregnancy or during pregnancy, these hormonal changes are magnified leading to adverse maternal and fetal outcomes. This study is done to evaluate the adverse effects of hypothyroidism during the antenatal period, maternal and fetal outcomes in patients with subclinical and overt hypothyroidism (OH).
Methods: The present prospective case–control study was conducted in the Department of Obstetrics and Gynaecology, Government Medical College and Rajindra Hospital Patiala, Punjab, from August 2018 to July 2019. The study was conducted among 150 antenatal patients, who had singleton pregnancy irrespective of age and parity. A complete thyroid profile was done to segregate them into euthyroid, subclinical hypothyroidism, and OH. Patients were divided into two groups, In group I, there were 75 antenatal patients who were euthyroid, and in group II, there were 75 antenatal patients with subclinical or OH diagnosed in pregnancy or already on treatment. The adverse maternal and fetal complications were noted in two groups. Data were compared using t-test for parametric data and Chi-square test for non-parametric data. Data presented as mean and standard deviation with p≤0.05 was considered statistically significant.
Results: In the current study, 4 (5.33%) patients in group II, 0 patient in group I had abortions giving p=0.011. 7 (9.3%) patients of group II, 0 patient in group I had intra uterine death giving a p=0.001. In group I, 1 (1.33%) patient, 8 (10.6%) patients in group II developed pregnancy-induced hypertension giving p=0.025. In group I, 6 (8%) patients, 25 (33.3%) in group II had preterm delivery giving p=0.018. In group I, 7 (9.33%) patients underwent induction of labor, and in group II, 19 (25.3%) patients were induced giving p=0.009. In group I, 2 (2.67%) patients, 10 (13.3%) patients in group II had undergone C-section giving p=0.006. In group I, 2 (2.67%) patients had fetal growth restriction babies as compared to 10 (13.3%) in group II giving p=0.006. In group I, 1 (1.33%) baby had an APGAR score <9 at 5 min and 15 (20%) in group II patients giving p=0.001. Neonatal intensive care unit admissions were 7 (9.33%) in group I as compared to 19 (25.33%) in group II giving p=0.018.
Conclusion: In the present study, it was observed that the prevalence of thyroid disorder in pregnant women is considerably high with subclinical hypothyroidism being most common followed by OH. A simple screening test of thyroid profile, if used to timely diagnose hypothyroidism a large number of maternal and fetal complications can be prevented.
Downloads
References
Tingi E, Syed A, Kyriacou A, Mastorakos G, Kyriacou A. Benign thyroid disease in pregnancy: A state of the art review. J Clin Transl Endocrinol 2016;6:37-49.
Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 2017;27:315-89.
Ajmani SN, Aggarwal D, Bhatia P, Sharma M, Sarabhai V, Paul M. Prevalence of overt and subclinical thyroid dysfunction among pregnant women and its effect on maternal and fetal outcome. J Obstet Gynaecol India 2014;64:105-10. doi: 10.1007/s13224-013-0487-y, PMID 24757337
Abiramavalli K, Vanitha D. Foeto maternal outcomes of hypothyroidism in pregnancy: A prospective study. IntJ Clin Obstet Gynaecol 2019;3:205-8.
Patel RD, Deliwala KJ, Shah PT, Singh RK. Fetomaternal outcome of thyroid disorder in pregnancy. Int J Reproduct Contracept Obstetr Gynecol 2016;5:4466-69.
Kalra B, Choudhary M, Thakral M, Kalra S. Prevalence of hypothyroidism in term pregnancies in North India. Indian J Endocrinol Metab 2018;22:13-5. doi: 10.4103/ijem.IJEM_189_17, PMID 29535930
Nazarpour S, Ramezani Tehrani F, Simbar M, Azizi F. Thyroid dysfunction and pregnancy outcomes. Iran J Reprod Med. 2015;13:387- 96. PMID 26494985
Jefferys A, Vanderpump M, Yasmin E. Thyroid dysfunction and reproductive health. Obstetr Gynaecologis 2015;17:39-45. doi: 10.1111/tog.12161
Mahadik K, Choudhary P, Roy PK. Study of thyroid function in pregnancy, its feto-maternal outcome; a prospective observational study. BMC Pregnancy Childbirth 2020;20:769. doi: 10.1186/s12884- 020-03448-z, PMID 33302910
Pokhanna J, Gupta U, Alwani M, Tiwari SP. Prevalence of thyroid dysfunction and impact on maternal and fetal outcome in Central Indian pregnant women. Int J Reprod Contracept Obstet Gynecol 2017;6:4666-70. doi: 10.18203/2320-1770.ijrcog20174461
Sreelatha S, Nadagoudar S, Asha D. The study of maternal and fetal outcome in pregnant women with thyroid disorders. Int J Reprod Contracept Obstet Gynecol 2017;6:3507-14. doi: 10.18203/2320-1770. ijrcog20173473
Bajaj S, Chawla T, Gupta P, Chaurasia A, Mehrotra R. Thyroid dysfunction in pregnancy-a tertiary care centre experience. Sri Lanka J Diabetes Endocrinol Metab 2018;6:7297.
Sibia P, Chaudhary A, Sibia R, Singh I, Jain M. Study of thyroid disorders in pregnancy. IOSR J Dent Med Sci 2019;18:39-48.
Singh G, Kaul I, Singh A, Meinia K. Maternal and fetal outcome in subclinical hypothyroidism in Jammu region, North India. Int J Reprod Contracept Obstetr Gynecol 2017;5:2362-66.
Ramachandran R, Mohan L, Jose S. Prevalence of thyroid disorders in antenatal women and its impact on maternal and foetal outcome. Indian J Forensic Community Med 2020;7:29-32.
Praveena R, Pramod R, Prasuna K, Krishna V. Prevalence of thyroid disorder in pregnancy and pregnancy outcome. Int Arch Integr Med 2018;5:113-8.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Daljeet Kaur, Dr. Beant Singh, Dr. Parneet Kaur, Dr. Shelly Khillan
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.